Biophytis S.A. (EPA:ALBPS)
France · Delayed Price · Currency is EUR 0.0153
0.00 (0.00%)
Jun 12, 2026, 5:35 PM CET
Biophytis Market Cap
Biophytis has a market cap or net worth of €1.4 million as of July 14, 2026. Its market cap has decreased by -51.58% in one year.
Market Cap
1.40M
Enterprise Value
7.88M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.02
Market Cap Chart
Since July 13, 2015, Biophytis's market cap has decreased from 45.17M to 1.40M, a decrease of -96.90%. That is a compound annual growth rate of -27.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 1.40M | -9.38% |
| Dec 31, 2025 | 1.55M | -44.45% |
| Dec 31, 2024 | 2.78M | -23.40% |
| Dec 29, 2023 | 3.64M | -51.74% |
| Dec 30, 2022 | 7.53M | -87.89% |
| Dec 31, 2021 | 62.22M | -32.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 19.27M |
| Aelis Farma | 14.28M |
| Poxel | 10.96M |
| NFL Biosciences | 10.77M |
| Aton | 8.78M |
| Plant Advanced Technologies | 7.19M |
| Oncodesign Precision Medicine Société anonyme | 6.53M |
| TME Pharma | 6.31M |